SATO VICKI L 4
4 · Denali Therapeutics Inc. · Filed Jan 3, 2025
Insider Transaction Report
Form 4
SATO VICKI L
Director
Transactions
- Sale
Common Stock
2025-01-02$20.91/sh−3,080$64,403→ 107,976 total
Footnotes (3)
- [F1]The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted March 21, 2024.
- [F2]The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $20.75 to $21.06 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- [F3]Includes 5,967 unvested RSUs.